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BiomarkerLeishmania is a neglected protozoan parasite which creates some problems for public health with differ-
ent clinical infections in different countries around. Due to the lack of an effective drug without side
effects and the emergence drug resistance, there is an urgent need to introduce the novel drug targets
and new drugs and vaccines to control leishmaniasis during recent years, metabolomics and other
‘‘Omics” platforms has become an important approach to comprehensive knowledge of the Leishmania
parasites biology. The study of metabolite profiles can open the insights for discovering novel therapeutic
targets in this infection in both of the parasites and human host. In addition, specifying the metabolomics
profile changes among promastigotes, amastigotes and during metacyclogenesis can pay the way for
achieving parasite survival parameters and the host-parasite interaction. The previous studies in this field
have been extracted from the databases, literature and their detailed major concepts. The present review
highlights the role of metabolomics approach in the field of Leishmania research. Also, several important
metabolite signatures introduced in various aspect of leishmania parasite such as drug resistance and
parasite biology which would be useful in the field of biomarker and drug discovery process. Finally,
metabolomics plays a potential role in introducing metabolic pathways related to Leishmania parasite
and its treatment design.
 2018 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an open
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Personal health is considered as one of the principles of health
care in the future. The system biology plays a significant role in
understanding the interactions of biological system at different
levels such as genomes, proteins, and metabolites. Recently,
‘‘Omics” approaches including genomics, proteomics, and metabo-
lomics analysis and also bioinformatics and computational predic-
tion are from the modern technologies which have gained much
attention in recent years to find potential markers for different dis-
eases using various biological samples such as tissues, biological
fluids and cell cultures.1,2 As one of the components of the system
biology, metabolomics is also rapidly developing, which has
attracted a lot of attention in various biomedical studies. In addi-
tion, the metabolomics research has a great potential for coming
into the medical arena.3–5 Metabolomics analyzes the whole
metabolites which are present within an organism in a specific
condition. Through detecting and quantifying all metabolites in a
specific sample, metabolomics provides a ‘‘snapshot” during the
metabolic changes related to the disease.6 In fact, metabolomics
studies reflect changes in the upstream stages of system biology
research (genome and proteome). Due to more dynamical status
of metabolomics rather than both genomics and proteomics anal-
ysis, this approach can detect metabolic changes associated with
different physiological states within a shorter time frame.3,7 A large
body of research emphasized the importance of metabolites as
invaluable biomarkers for diagnosing and detecting disease.
However, metabolomics can detect and introduce biomarkers in
a broad range of samples such as whole blood, serum, plasma,
urine, saliva, and the like in various disease conditions82. Leishmania and leishmaniasis
Protozoan Leishmania causes a wide spectrum of clinical disease
among humans, which is globally regarded as a major public health
problem in the Middle-East.9 Leishmaniasis is a vector-borne dis-
ease which is transmitted by sandflies and caused by obligate
intracellular protozoan of the genus Leishmania. Human infection
appears by about 20 species of parasite which are transformed to
human through biting by sand-fly vector.10 Different species are
morphologically the same although they are different by•logarithmic phase in vitro
•free extracellular
•sandfly  vector stage
•divide in midgut of sandfly
•flagellate and mole form




Fig. 1. Different forms of Leishmania parasites during their infectious cycle. Procyclic p
develops into the metacyclic promastigotes forms. Transformation of procyclic to metacy
in to intracellular amastigote forms in macrophage cells.isoenzyme analysis. These species include the L. donovani complex
with two main species such as L. donovani, L. infantum, the
L. mexicana, L. tropica, L. major and L. aethiopica and the subgenus
L. viannia with four main species. It is estimated that over 350 mil-
lion people are at risk for leishmaniasis, among whom 12 million
were infected and 1.5–2 million new cases are globally reported
each year.9,11 There are several different forms of leishmaniasis
in the human based on species-dependent disease, ranging from
self-healing skin ulcers in cutaneous leishmaniasis to the most
severe pathologies associated with visceral leishmaniasis by
L. donovani, L. infantum and L. chagasi,which is fatal if it is not trea-
ted appropriately.12 Cutaneous leishmaniasis is the most common
form of leishmaniasis and L. major and L. tropica are the main cause
for this form of leishmaniasis making skin lesions.13 The
Leishmania parasite has a dimorphic life cycle including an infec-
tive promastigote form inside the gut of the sand-fly, which are
transmitted with saliva into a human host during blood feeding.
Within the mammalian host, promastigotes are rapidly engulfed
by phagocytic cells at the infection site and undergo cyto-
differentiation to the amastigote stage within the phagolysosome
of the host macrophage with acidic environment Fig. 1. The differ-
entiation of the promastigote form into the amastigotes is deter-
mined by several morphological and biochemical changes which
are essential for surviving and propagating parasite during accom-
modation in phagolysosome vacuoles. Interestingly, promastigote
forms can be easily cultured in vitro and the amastigotes of some
Leishmania species can be proliferated in cell free medium14,15
Thus, most studies were conducted on the promastigote form
and axenic amastigote and in the meantime, metabolomics studies
also are no exception.3. Metabolomics
The metabolomics is a part of ‘‘Omics” science in system biology
which has been developing for understanding the alteration of
molecular level in disease conditions. Metabolomics, along with
other ‘‘Omics” platforms such as genomics, transcriptomics and
proteomics, can complete the systemic view of biology in different
research areas.16 Metabolomics is defined as an informative analyt-
ical tool for metabolites measurement in both quantitative and




•intracellular form in 
macrophage phagolysosome
•non- flagellate
romastigotes exist in the gut of sand-fly vector and divide quickly. Then this form
clic is named metacyclogenesis process. In mammalian hosts metacyclic transforms
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rich by metabolites, their concentration assessment, and flux
through metabolic pathways. The development of metabolomics
and conducting a large body of research in this area are regarded
as some evidence of the progression and applicable presence of
metabolomics in many areas.18 Identification of the changes in
metabolites level can help to diagnose disease in early stages.
Metabolites are small endogenous molecules and the end products
of biochemical pathways with low molecular weight between
1500 Da and less such as lipids, peptides, organic acids, nucleic
acids, amino acids, vitamins and carbohydrates which metabolo-
mics allow for profiling the metabolites globally in various biolog-
ical samples such as blood, tissue, urine and the like.19 The
metabolites are invaluable small molecules playing an important
role in biological systems and representing useful data to under-
stand disease phenotypes.20 In addition, profiling metabolite mark-
ers and their amounts is regarded as an important method for
diagnosing the disease in early stages. Comparative metabolomics
by metabolite profiling from different conditions (e.g. disease vs.
control) resulted in detecting metabolic changes and supporting
the inference of different aspects of the disease such as molecular
mechanisms, biochemical pathways, disease prediction or progres-
sion, and even screening markers of early diagnosis.21 Metabolites
variation levels are applied as the prediction of disease before clin-
ical symptoms of disease. Regarding the metabolomics field, tar-
geted and non-targeted approaches are available as two main
categories. Based on targeted approach, specific and known groups
of metabolite are associated with certain metabolic pathways
while non-targeted approach focuses more on all possible metabo-
lite analyses in any sample in certain condition. Thus, the second
approach is preferred.22 Biomarker discovery for various diseases
and integrative system biology are considered as the most com-
mon areas for metabolomics analysis. Biomarker discovery by
using metabolomics tool is a promising approach for disease diag-
nosis in the early stage before appearing the related symptoms. A
comprehensive profile of metabolites in biological specimen is
defined as metabolomics.21 In addition, a large number of tech-
niques are used for profiling metabolites, among which we can
refer to one dimensional proton nuclear magnetic resonance
(1H NMR) and mass spectrometry (MS) as the most commonly
used techniques. The development of metabolomics-based studies
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Fig. 2. The metabolomics-based study of Leishmania parasite process for NMR and LC-MS
from each other which applying appropriate protocol could be obtain better results. The s
the identification of metabolite targets for chemotherapeutic treatment and introducingseparation methods, integrated with MS.23 Based on MS-based
metabolomics experiments, the quantitative analysis of metabo-
lites is performed with high sensitivity while using sample com-
plexity reduction prior to detection can simplify the
identification of metabolites based on LC-MS approach. The type
of biological sample is very important in choosing the technique
in metabolomics. Recently, the detection of metabolites and their
metabolic pathways is made possible by advanced techniques-
based MS such as GC-MS, HPLC-MS, UPLC-MS and CE-MS. Each of
these applied analytical platforms for detecting metabolites has
its own advantages and disadvantages. Thus, these platforms can-
not individually detect all metabolites in biological samples. There
are metabolome analyses of many types of organisms conducted
for obtaining information about metabolic pathways. Therefore,
an appropriate metabolomics analysis is required to obtain full
understanding of Leishmania metabolic pathways in different
aspects of this parasite. The quality of sample preparation is very
important for achieving high quality results. This step should be
highlighted in different resources of biological samples in
Leishmania and an individual protocol is necessary for assessing
the metabolome profile of cultured parasite (108 cells) by NMR
or MS-based methods Fig. 2.
3.1. Analytical approach in metabolomics
3.1.1. NMR (Nuclear Magnetic Resonance)
NMR is considered as one of the most commonly used analytical
platforms in metabolomics. Single proton 1H NMR involves the use
of a large and powerful magnet to align the protons which are
available in a sample. In this method, each metabolite appears with
a distinct peak in the NMR spectrum and the area under the peak
represents each metabolite concentration. The advantages and dis-
advantages of this method are summarized in Fig. 3. One of the
most important advantages of NMR for detecting metabolites in
this method is that the sample is not degraded and it is even used
in subsequent studies.3 Low sensitivity and detection of limited
mass range are regarded as the limitation of NMR. The general pro-
cess of NMR-based metabolomics includes the following steps16
 Experimental design
 Sample preparation
 NMR raw datan 4° c, Washed in ice 
 saline 
Chilled perchloric acid 
uspension 
nd centrifuge in 4°c 
ce cold normal saline 
n ice for 1h (for 







 dry ice/ethanol bath 
n at  4°c 
methanol/water 
xtracon on ice 
.5 h at  4°c 
LC- MS 
analysis 
analysis. Sample preparation step of cells for NMR and MS-base analysis is different
tudy of the metabolome of Leishmania-infected cells using metabolomics, can lead to
of novel molecular markers that can be used for the diagnosis of different diseases.
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required
•Sample analysis is fast (~ 7 min)
•All kind of small- molecule 





•More than one peak per 
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meaning spectra are oen 
complex
•Does not analyse fats and lipids 
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•Robust and reproducible 
technique
•Large dynamic range
•Compound idenficaon is 
facilitated by large, well-
established mass spectral libraries
•Disadvantags:
•Sample analysis can be slow (20-
30 min per sample)
•The similarity of isomers can 
make it difficult to idenfy 
compounds
•Many metabolites are non-
volale and must be derivezed 
prior to analysis
•Many large molecules (e.g. 





•No derivazaon required 
(usually)
•Disadvantages:
•Analysis can be slow
•Reproducibility issues and matrix 
effects can hinder compound 
idenficaon
•There are very few commercial 
libreries
Liquid chromatography- mass 
spectrometry (LC- MS) 
Gas chromatography- mass 
spectrometry (GC- MS) 
Fig. 3. A summary of the most common analytical techniques (with advantages and disadvantages) used in metabolomics.
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 Data preprocessing
 Multivariate data analysis (PCA, PLS-DA, OPLS-DA)
 Metabolic pathway identification (potential biomarkers)
3.1.2. MS-based techniques
Metabolite spectrum data are considered as mass-to-charge
(m/z) ratios by MS.24 MS is primarily coupled with liquid chro-
matography or gas chromatography in metabolomics studies.3 It
is worth noting that the use of LC-MS in metabolomics studies
results in detecting a wide range of metabolites.25 Regarding some
idiosyncratic properties of LC-MS method, we can refer to the
simultaneous assessment of aqueous and lipid metabolites, more
separation, and detection of different types of metabolites.26 This
method covers a greater mass range and no derivation of samples
is required. However, the variability of LC-MS instruments and
absence of standard metabolic library are considered as the disad-
vantages of this approach Fig. 3.27 In order to detect metabolites by
LC-MS, some steps should be taken such as separating by chro-
matography, ionizing the sample, determining the compound mass
by mass analyzer, and detecting the metabolites by detector. TOF
and quadrupole are regarded as the most common mass analyzers
coupled with LC. During recent years, some advance techniques
such as FT-ICR with high mass accuracy and consecutive MS (tan-
dem MS) ability has attracted a lot of attention. However, it is less
implemented due to the high cost of FT-ICR. GC is another separa-
tion method which is coupled with MS. GC-MS is used for separat-
ing and detecting volatile metabolites at high temperature with
high sensitivity. The efficiency of this method is related to the high
sensitivity and the detection of volatile metabolites capability.
However, regarding the major challenges of GC-MS, we can refer
to the derivation of readily volatile samples and limited mass range
that incomplete derivation can lead to loss of metabolite and intri-
cate explanation of results.26
3.2. Statistical analysis of metabolomics-based data
Multi-dimensional dataset includes the signal from a large
number of metabolites generated in metabolomics studies. Thus,developing a coherent hypothesis explaining any changes in
metabolite profile by intuition alone is difficult due to a large num-
ber of measurements. Therefore, employing a multi-dimensional
statistical analysis is essential for reducing the number of variables
in a dataset. The most commonmethods used for reducing data are
related to unsupervised methods such as PCA and supervised
methods including PLS, PLS-DA.28 PCAmethod is utilized for outlier
identification within the dataset. Then, PLS-DA and OPLS-DA as
unsupervised multivariate data analytical methods are performed
for 1H NMR spectral data analysis. PLS-DA is considered as a
pattern recognition approach used to identify potential disease-
specific biomarkers. After identifying the metabolites, their
interpretation into biological process and pathways is an impor-
tant step in analyzing the results of metabolomics study.29 The
existence of valid database including invaluable information about
metabolites and the involved pathways play a significant role in
mapping metabolites on biological system. There are a number of
public information databases about metabolites and their reac-
tions, as well as some of open source tools such as MetaCore which
provide some helpful ways to experimentally map the observed
changes of metabolites into metabolic pathways.3,30 Finally, the
data are imported into the Metscape plugin by Cytoscape software
for more analysis of differentiated metabolites in the groups under
study. Metscape plugin use to map of the pathway of metabolo-
mics data. Finally, this application demonstrates seed metabolites,
metabolic reactions, enzymes, and genes.3,314. Metabolomics and Leishmania/leishmaniasis
Recently, a number of metabolomics-based studies have been
published with respect to Leishmania/leishmaniasis. Metabolomics
as a new field in post-genomic era represents an emerging
discipline related to a comprehensive analysis of small molecule
metabolites, which provides a powerful approach to discover
biomarkers in biological systems. L. major Fredlin strain is the first
protozoan model which metabolic network was reconstructed by
Chavali et al.32 In this regard, NMR and MS spectrometry are
considered as the most useful methods.
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research
Most of the studies in the field of Leishmania by 1HNMR-based
metabolomics have been conducted on life cycle stages in meta-
bolic changes of parasite in different species. However,
metabolomics-based studies about the drugs affected metabolo-
mics map have been less emphasized and only one study was
reported on blood serum of cutaneous leishmaniasis. Table 1 indi-
cates all of the previous studies on Leishmania by 1H NMR-based
metabolomics. Arjmand et al.33 focused on metabolomics by using
1H NMR in order to compare two stages of promastigote forms of
parasite including procyclic and metacyclic in L. major species.
The main altered metabolites in logarithmic and stationary phases
included citraconic acid, isopropylmalic acid, L-leucine, ornithine,
caprylic acid, capric acid, and acetic acid. Amino acids play an
important role in energy production in Leishmania parasite.34 The
major alterations in amino acids in metacyclogenesis process
include citraconic acid, isopropylmalic acid, L-leucine related to
valine, leucine and isoleucine biosynthesis pathways, respectively.
In the present study, caprylic and capric acids in fatty acid biosyn-
thesis pathway indicated some alterations between the two
phases. Based on the results of the previous studies, the oxidation
rate in fatty acids is faster in stationary phase rather than the log-
arithmic phase, which is consistent with the results of previous
studies.35 The final significant change in metabolites is related to
acetic acid in pyruvate and sulfur metabolic pathways. In the men-
tioned study, the detection of metabolite alterations could be help-
ful for better understanding of metacyclogenesis process and
reopening new horizons in control of disease. In another study,
Boroujeni et al.,36 performed NMR-based approach for metabolic
profiling of L. major in the control group (without artemisinin
reception in culture media) and the case group (with artemisinin
reception in culture media). Based on the results, the mostTable 1
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Metabonomic Study on Samples of Cutaneous Leishmaniasis and
its Correlation with the Selenium Level in the Blood Serum
T
1H NMR; one dimensional proton nuclear magnetic resonance.significant changes were related to galactose metabolic cycle.
Other significant metabolites belong to sphingolipid, valine, leu-
cine and isoleucine biosynthesis pathways. The results showed
that galactose metabolism is the most important pathway in cuta-
neous leishmaniasis pathogenesis and can be considered as an
important drug target in parasite extermination. According to sph-
ingolipid role in apoptosis, the results of this study on the changes
of this metabolic pathway indicate that artemisinin is effective for
parasite clearance. Drug resistance represents a major challenge
for controlling leishmanial infectious. In addition, based on the
results, antimonial (sodium stibogluconate; SSG) resistance was
closely related to metacyclogenesis process in L. donovani as SSG-
resistant strains could increase the capacity for generating
metacyclic-infective forms. Also, by using 1H NMR, Lamour et al.,37
characterized the cell growth medium, parasite extract and intra
and extracellular metabolome of activated and non-activated
macrophages in the presence and absence of L. major. The results
demonstrated some metabolic differences between infection state
and macrophage activation. Succinate, acetate, and alanine
metabolites placed at higher level in the samples exposed to para-
site, compared to uninfected macrophages. Furthermore, Gupta
et al.,38 characterized map/profile of in vitro cultured axenic
amastigote metabolites, compared to intracellular amastigote
and promastigote forms employing proton NMR spectroscopy. In
this study, two new metabolites including betaine and
b-hydroxybutyrate were reported. It is worth noting that betaine
was presented in all of parasite forms while b-hydroxybutyrate
was identified only in the promastigote and axenic amastigote
stages. Among other metabolites, acetoacetate could only be
detected in axenic and intracellular amastigote stages. All the
remaining metabolites were present at all three stages of parasite
which were considered in the present plan with different levels.
Tafazzoli et al.,39 in another study, utilized a non-targeted study
by using gas NMR in order to compare the metabolite profiling ofearch.
bolites/Metabolic Pathways Ref.
aline, leucine, and isoleucine biosynthesis: Citraconic acid, isopropylmalic
cid, L-leucine
yruvate metabolism: Acetic acid, isopropanol
lutathione metabolism: Ascorbic acid, ornithine
atty acid biosynthesis: Caprylic acid, capric acid
ulfur metabolism: Acetic acid
33
alactose metabolism: a-D-glucose 6-phosphate, melibiose, raffinose, lactose
taciose
tarch and sucrose metabolism: Amylase, a-D-glucose 6-phosphate
phingolipid metabolism: Sphingosine, Sphingaine valine, leucine, isoleucine
iosynthesis: Threonine biotin metabolism : pimelate, 6-carboxyhexanol coA
36
iscriminating Metabolites Associated with L. major Infection:
ell culture supernatants: Acetate, Alanine, Citrate, Fumarate, Glucose,
actate, Ornithine, Pyruvate, Succinate
ell Extracts: Acetate, b-Alanine, Citrate, Creatine, Creatine Phosphate,
lycerophosphocholine, Glycine, Lactate, Phosphocholine, Taurine
iscriminating Metabolites Associated with Macrophage Activation:
ell culture supernatants: Acetate, Alanine, Citrate, Glucose, Glycine, Lactate,
rnithine, Pyruvate, Succinate
ell Extracts: Acetate, b-Alanine, Citrate, Creatine, Creatine Phosphate,
lucose, Glycerophosphocholine, Glycine, Lactate, Phosphocholine, Taurine
37
ommon metabolites in three stages: succinate, lactate, a-glycerophosphoryl
holine (a-GPC), betaine, arginine, alanine, valine
romastigote and axenic amastigte metabolites: bhydroxybutyrate
xenic and intracellular amastigote metabolites: acetoacetate
38
hreonine, Lipid, Lactate, Alanine 39
388 N.A.D. Atan et al. / Alexandria Journal of Medicine 54 (2018) 383–39020 leishmaniasis patients sera and 44 healthy individuals. In addi-
tion, they measured the concentrations of selenium in all 64 serum
samples by using an atomic absorption device. In this study, PCA
and PLS methods were applied for distinguishing the outliers and
classifying the patients based on selenium concentration in blood
serum. The most important metabolites were related to threonine,
lipids, lactate and alanine. The findings of this study indicated a
significant relationship between selenium concentration and the
related variables. In case of drug resistance mechanism evaluation
in leishmania, Rainey and Mackenzie, 1991 performed metabolo-
mics study in order to clarify the drug resistance mechanisms in
Leishmania species which is regarded as a problem in treatment
output.40
4.2. MS-based metabolomics in the leishmania/leishmaniasis research
Metabolomics studies based on mass spectrometry are proving
of great utility in the analysis of different aspects of protozoan par-
asites such as leishmania genus. Metabolomics has also given
insight into the biology, pathogenesis, mechanisms of drug against
parasites and also drug resistance in leishmania. The list of LC-MS-
based metabolomics studies along with details of the studies are
summarized in Table 2. In a metabolomics investigation, Akpunar-
lieva et al.,41 integrated proteomics and metabolomics approaches
to identify proteins andmetabolites, which represent altered abun-
dance in mutant L. Mexicana (DLmGT) promastigotes. In this study,
the molecular variations of wild-type and mutant model of
Leishmania were investigated in proteome and metabolome levels.Table2











Comparative analysis of the metabolomes of promastigotes of
L. donovani, L. major and L. mexicana
L. infantum (LC-MS) Elucidation of the metabolic changes involved in miltefosine
action on JPCM5 promastigote cell line
L. donovani (LC-MS) Identification of metabolic differences on three different
levels: (i) during in vitro promastigote growth; (ii) between
strains with a different drug susceptibility; and (iii) when a
resistant strain is maintained under drug pressure
L. donovani (LC-MS) Untargeted metabolite profiling and comparison their levels
between L. donovani Promastigotes during in vitro culturing
from logarithmic to stationary phase
L. donovani (LC-MS) Characterization of the global metabolic differences between
antimonial-sensitive and antimonial-resistant L. donovani
isolates
L; Leishmania, LC-MS; liquid chromatography, GC-MS; gas chromatography, LOG; logari
significant decrease.
* Untargeted metabolomics platform.
** Targeted metabolomics platform.The results indicated some variations such as deficiency in glucose
transport and several phenotypic changes in mutant model, as well
as seeking molecular interpretation of these phenotypes. In addi-
tion, the results demonstrated a series of changes in metabolic
pathways of glycoconjugate production and redox homeostasis
involved in glucose metabolism in response to oxidative stress,
which may represent the compatibility to the loss of sugar uptake
capacity and elucidate the low virulence of this mutant among the
hosts. In other study, Westrop et al.,42 compared the metabolome
profile of promastigotes of L. donovani, L. major and L. mexicana
by LC-MS technique. The analysis revealed 64 metabolites with
confirmed identity differing 3-fold or more between the cell
extracts of species and 43 metabolites of confirmed identity in cul-
ture media of species, respectively. Furthermore, the recognized
metabolites were detected in cell extracts of three species and
their culture media included 161 and 87 metabolites. Significant
differences in metabolic pathways were observed in amino acids,
especially Trp, Asp, Arg and Pro, compared to the global metabo-
lome of the studied Leishmania spp. This study failed to play a role
in detecting inter-species differences about metabolic adaptation
of parasites in their hosts. In this regard, Vincent et al.,43 imple-
mented an untargeted LC-MS metabolomics approach to clarify
the metabolic profile changes involved in miltefosine action at
time intervals of 0, 1.25, 2.5, 3.75 and 5 h of drug treatment in
L. infantum species. Totally, 876 metabolites were detected, among
which alkane fragment and sugar release related to metabolites
significantly altered after 3.75 h. Fragment release was concurrent
with ROS production, while no changes has occurred in membrane.
Metabolites Ref.
Glycerol, Nicotinate, Phosphoethanol-amine, Glutamate
5-semialdehyde, Ovothiol A disulfide, Cytosine, Phosphocholine, Betaine,
2-Oxoglutaramate, Dihydroorotate, Deoxyribose,
L-Glutamate,
L-Aspartate, L-Alanine, Glutathione, Succinate
41
Differentiated confirmed metabolites between the cell extracts of
three species: 64 metabolites
Differentiated confirmed metabolites between the cell extracts of
three species: 43 metabolites
Number of confirmed and putative metabolites: 355 metabolites
Large differences metabolites : tryptophan, aspartate, arginine and
proline
42
Over 800 metabolites detected, 10% of which were significantly altered
after 3.75 h(many of the changes related to an increase in alkane
fragment and sugar release)
43
Differential Significant decreased metabolites between
BPK275_SbIII and BPK275:
LOG: butyryl-, capryloyl-, valerylglycine, 2 fatty acyls, 2-oxoarginine and
acetyllysine
STAT: Xanthosine 50-phosphate, trypanothione, low unsaturated GPL
Differential metabolites change in resistant VS. sensitive strains growth
stages:
Up LOG R/LOG S: GPL building blocks
Up STAT R/STAT S: Unsaturated GPLs, Amino acids, Purine nucleosides,
Sugar phosphates
Down LOG R/LOG S: Nucleobases and nucleosides
Down STAT R/STAT S: Saturated GPLs
44
Alchols, amines, amino acids, carbohydrates, fatty acyls, glycerolipids,
glycerophospholipids, heterocyclic moleculs, ketones and aldehydes,
nucleosides, organic acids, SL and sphingoid bases, sterol and prenol
lipids, vitamins and cofactors
45
Glycerophospholipids, sphingolipids and bases, glycerolipids, sterol and
prenol lipids, amino acids, polypeptides and conjugates, purines/ pyrim-
idines and conjugates, miscellaneous
46
thmic growth stage, STAT; stationary growth stage, up; significant increase, down;
N.A.D. Atan et al. / Alexandria Journal of Medicine 54 (2018) 383–390 389phospholipids. In addition, the levels of some thiols and polyami-
nes changed indicating DNA damage in the treated cells. Due to cell
membrane damage, the evacuated levels of most metabolites
occurred after 5 h of miltefosine treatment. In miltefosine resistant
cells, no change was found in the internal metabolites levels. The
results are important for understanding miltefosine and can be
regarded as fundamental information in designing treatment pro-
gram. In this respect, Berg et al.,44 implemented an untargeted
LC-MS platform for evaluating the metabolic differences of
L. donovani during promastigote stages in the absence or presence
of drug pressure. The study presented new approaches in the con-
text of antimonial resistance and differentiation. The results of
metabolites changes demonstrated that the SSG-resistant parasites
can play a significant role in encountering with oxidative stress
process. Further, Silva et al.,45 applied an untargeted metabolomics
approach for evaluating the metabolic changes during promastig-
ote by developing in vitro culturing between 3 and 6 days. Based
on the results, the metabolome profile of promastigotes differed
significantly from each other during culture. The most striking
metabolic differences were related to the structural variations in
glycerophospholipids and an increase in the amount of sphin-
golipids and glycerolipids as cells progressed from procyclic to
metacyclic stages. Furthermore, Kindt et al.,46 implemented an
untargeted LC-MS metabolomics approach to global comparative
metabolic profiling of antimonial-sensitive and antimonial-
resistant L. donovani isolates. They determined the antimonial-
sensitive and antimonial-resistant differences by using
metabolomics study and measured the relative abundance of 340
metabolites and a large number of lipids. Based on the results,
distinct metabolic profiles were observed in drug-sensitive and
drug-resistant parasites and significant differences were shown
between two phenotypes among100 metabolites. The most signif-
icant difference in metabolites was related to the pathways of lipid
metabolism. However, the results failed to involve resistance
mechanisms for antimonial drugs. Also, in the field of comparative
metabolomics of wild type and mutant parasite model, De Souza
et al.,47 described a GC-MS peak clustering approach for discrimi-
nating the wild-type of L. Mexicana from two mutant parasite lines
based on their metabolic profile.5. Conclusion
Leishmania as a protozoan parasite is considered as an
etiological agent of wide range of clinical manifestations known
as ‘‘leishmaniasis”. The disease represents a major public health
problem and is endemic in 98 countries across five continents.
However, no effective vaccine and decisive treatment has been
introduced yet. Over the past few years, ‘‘Omics” technologies have
played a pivotal role in recognizing parasite biology in its different
life cycle stages, identifying the parasite-host interaction, and
introducing novel drug target. Metabolomics approach based on
a large-scale study of metabolite profiles both in parasite and the
host can accelerate the discovery of novel metabolite markers
and reveal their related biochemical pathways to understand the
underlying pathology of leishmaniasis. In addition, metabolomics
approach has attracted a lot of attention among researchers, due
to the regulation of gene expression of trypanosomatidae in post-
transcriptional level. This review provides a reference including
all studies in the field of Leishmania metabolomics. In most of the
conducted studies, metabolomics-based study of L. donovani, L.
major and L. mexicana spp. was investigated by LC-MS and NMR
methods while other species such as L. tropica, L. infantun, etc. were
neglected. The most common objectives in these studies are
related to a comparative metabolomics of the biology of Leishmania
parasite in different stages such as procyclic, metacyclic andamastigote. However, a few studies were conducted by using bio-
logical samples of mammalians hosts for example blood, urine and
tissue samples in response to infection. In this respect, the results
of the study on blood serum of cutaneous leishmaniasis showed
that the most important metabolites include threonine, lipid, lac-
tate and alanine. Further, the limitation of metabolomics study of
parasite isolates has great potential to increase our understanding
of metabolism in the clinically relevant stage. The study of drug
resistance and drug action by metabolomics obtain some impor-
tant information about designing integrated therapies, under-
standing parasite metabolism, and highlighting some new targets
for chemotherapy important. In metabolomics-based study, the
study of metabolic pathways in natural plant-derived products is
very critical in confronting the disease in a natural program with
the least amount of side effects. The present review will provide
a reference to conduct new studies for better understanding of
the pathways playing a role in the biology of Leishmania and its
control. Additionally, the integration of metabolomics with other
platforms of system biology such as genomics, transcriptomics,
proteomics and lipidomics will provide further and better insights
into evaluating different pathophysiology aspects and treating the
disease.
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